Can brain stimulation plus cognitive training improve thinking in Alzheimer disease and mild cognitive impairment?

For people with Alzheimer disease or mild cognitive impairment—a slight, noticeable change in memory or thinking skills not severe enough to affect daily tasks—adding brain stimulation from outside the head to guided practice in thinking tasks produced better overall cognition scores immediately after treatment than comparison groups who received only part of the treatment or an inactive one. The clearest results appeared in people with Alzheimer disease and in those receiving the magnetic-pulse form called repetitive transcranial magnetic stimulation (rTMS). How long any benefit lasts is uncertain: later checks between two weeks and six months showed advantages mainly in those same groups, not in everyone, and nothing is known beyond six months. These findings are about test scores, not everyday memory or independence.

What the treatment looked like

Cognitive training means guided practice on tasks that target specific thinking skills such as memory, attention, or problem-solving. In the included trials, training often used computers or tablets and included tasks like naming words, matching faces to names, arithmetic, language, and remembering object locations. Brain stimulation in this review had two main forms. Repetitive transcranial magnetic stimulation (rTMS) places a small coil on the scalp that delivers brief magnetic pulses. Transcranial direct current stimulation uses a weak electrical current that mainly changes the resting state of brain cells in a shallower, broader area. Most trials delivered stimulation at the same time as training; a few gave one before the other.

The review team selected published randomized trials of this combination in people aged at least 60 with Alzheimer disease or mild cognitive impairment. In total, 15 studies with 685 patients met the eligibility rules, but the main overall-cognition calculation was based on 12 of those studies with 591 patients because some studies did not report that score. Trial quality was generally rated good or excellent, but no trial could keep the person delivering treatment unaware of which treatment was given, and four trials had higher risk of bias.

Each trial compared the full combination against people who did not receive both real parts at once. Controls could receive inactive sham stimulation plus real training, real stimulation plus sham training, training alone, stimulation alone, or a placebo. This means the reported benefit is measured against people who received only one real part or an inactive one, not against doing nothing at all.

What changed right after treatment

Overall cognition is a single summary score that combines several mental abilities at once, such as from the Mini-Mental State Examination, rather than a separate memory or language measure. When the 12 studies with 591 patients were combined, people receiving the full treatment had better overall cognition scores right after the program than comparison groups. The benefit appeared moderate, but because the studies varied, the exact size is uncertain; the combined result was still consistent enough to count as an improvement in this analysis. Looking separately at stimulation type, the magnetic-pulse group improved overall cognition, while the electrical-stimulation group did not show a clear overall benefit. Looking at diagnosis, people with Alzheimer disease clearly improved, but there was not enough evidence to say whether mild cognitive impairment improved overall cognition.

When studies that reported separate abilities were pooled, most specific abilities did not clearly improve at the end of treatment: scores for executive function, attention/working memory, and memory were not clearly different from comparison groups. The exception was language. In the three studies using electrical stimulation plus cognitive training, language scores improved, though the authors advise caution because only three studies with 245 patients contributed and one large study carried much of the weight.

What happened weeks and months later

Follow-up checks occurred at different times between two weeks and six months after treatment ended. When all patients were put together, overall cognition at follow-up was not clearly better than comparison conditions. However, in subgroup analyses, patients who received magnetic rTMS plus cognitive training still had better overall cognition at follow-up. Patients with Alzheimer disease also still had better overall cognition at follow-up, and their attention and working-memory scores improved at follow-up as well. In people with mild cognitive impairment, follow-up attention/working memory and memory scores did not clearly improve. So the lasting benefit is not established for everyone; it appears mainly in people with Alzheimer disease and in those receiving the magnetic-stimulation combination.

Why magnetic and electrical stimulation may differ

The authors suggest possible explanations, but these are their interpretations and were not directly proven by these studies. Magnetic rTMS is more focused and reaches deeper brain areas and directly triggers electrical activity in brain cells. The electrical current method affects a shallower and wider brain surface and is weakened more by skin and skull, which the authors think may make the partnership between electrical stimulation and training weaker. They also propose that when stimulation is combined with training, the two may work together: stimulation may make brain networks more responsive while the training exercises specific skills.

What this can and cannot tell us

Taken together, the authors concluded that the combination, especially rTMS plus cognitive training, has short-term and follow-up effects on overall cognition, mainly in people with Alzheimer disease, and that electrical stimulation plus cognitive training has an advantage on language function. These findings measure performance on cognitive tests. They do not show that the treatment prevents or cures Alzheimer disease, and the review did not report whether patients' daily activities improved. Different trials used different test scales, which may add uncertainty. The authors call for more studies of specific cognitive domains and of mild cognitive impairment.